VB

Vennela Bhimavarapu

Active Director Director DIN 10132616
DIN 10132616 First appointment Apr 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Vennela Bhimavarapu

Data last updated:

Vennela Bhimavarapu is a Director at Uterx Healthcare Private Limited (since 2023). Uterx Healthcare Private Limited reported revenue of ₹3,293 (FY 2025).

DIN 10132616
Primary Designation Director
First Appointment 25 Apr 2023
Oldest Company Age 3 yrs
Largest company Uterx Healthcare Private Limited · ₹3,293 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Uterx Healthcare Private Limited U86909AP2023PTC110909
Director25 Apr 20232023₹3,293 (FY 2025)Active

Board colleagues of Vennela Bhimavarapu

NameDINCompanyDesignation
Sambi Reddy Bhimavarapu02985074Uterx Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Uterx Healthcare Private Limited
Premium access

Shareholding and investment profile for Vennela Bhimavarapu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vennela Bhimavarapu

Vennela Bhimavarapu currently holds 1 directorship: Uterx Healthcare Private Limited (Director, since 25 Apr 2023, revenue ₹3,293 (FY 2025)).

Vennela Bhimavarapu was first appointed on 25 Apr 2023 as Director at Uterx Healthcare Private Limited.

The current boards of Vennela Bhimavarapu's companies include Sambi Reddy Bhimavarapu (Uterx Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available